Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Metabolism of triglyceride-rich lipoproteins in health and dyslipidaemia
Jan Borén, Marja‐Riitta Taskinen, Elias Björnson, et al.
Nature Reviews Cardiology (2022) Vol. 19, Iss. 9, pp. 577-592
Closed Access | Times Cited: 144

Showing 1-25 of 144 citing articles:

Genetic association of lipids and lipid-lowering drug target genes with non-alcoholic fatty liver disease
Ziang Li, Bin Zhang, Qing‐Rong Liu, et al.
EBioMedicine (2023) Vol. 90, pp. 104543-104543
Open Access | Times Cited: 79
Triglyceride-rich lipoprotein remnants, low-density lipoproteins, and risk of coronary heart disease: a UK Biobank study
Elias Björnson, Martin Adiels, Marja‐Riitta Taskinen, et al.
European Heart Journal (2023) Vol. 44, Iss. 39, pp. 4186-4195
Open Access | Times Cited: 76
Duplex Responsive Nanoplatform with Cascade Targeting for Atherosclerosis Photoacoustic Diagnosis and Multichannel Combination Therapy
Hong Xu, Peiyi She, Zhiyu Zhao, et al.
Advanced Materials (2023) Vol. 35, Iss. 21
Closed Access | Times Cited: 45
Elevated blood remnant cholesterol and triglycerides are causally related to the risks of cardiometabolic multimorbidity
Yimin Zhao, Zhenhuang Zhuang, Yueying Li, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 21
VLDL Biogenesis and Secretion: It Takes a Village
Willemien van Zwol, Bart van de Sluis, Henry N. Ginsberg, et al.
Circulation Research (2024) Vol. 134, Iss. 2, pp. 226-244
Open Access | Times Cited: 19
Understanding the cause of type 2 diabetes
Roy Taylor
The Lancet Diabetes & Endocrinology (2024) Vol. 12, Iss. 9, pp. 664-673
Closed Access | Times Cited: 15
Apolipoprotein B-containing lipoproteins in atherogenesis
Jan Borén, Chris J. Packard, Christoph J. Binder
Nature Reviews Cardiology (2025)
Closed Access | Times Cited: 2
Flavonoids for gastrointestinal tract local and associated systemic effects: A review of clinical trials and future perspectives
Xiaopeng Li, Enjun Xie, Shumin Sun, et al.
Journal of Advanced Research (2025)
Open Access | Times Cited: 2
Insights Into Causal Effects of Genetically Proxied Lipids and Lipid‐Modifying Drug Targets on Cardiometabolic Diseases
Liwan Fu, Qin Liu, Hong Cheng, et al.
Journal of the American Heart Association (2025)
Open Access | Times Cited: 2
Evaluation of the value of conventional and unconventional lipid parameters for predicting the risk of diabetes in a non-diabetic population
Guotai Sheng, Maobin Kuang, Ruijuan Yang, et al.
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 46
The Potential Cardiometabolic Effects of Long-Chain ω-3 Polyunsaturated Fatty Acids: Recent Updates and Controversies
Jae Hyun Bae, Hyunjung Lim, Soo Lim
Advances in Nutrition (2023) Vol. 14, Iss. 4, pp. 612-628
Open Access | Times Cited: 35
Inflammation and Insulin Resistance in Diabetic Chronic Coronary Syndrome Patients
Tianyu Li, Peizhi Wang, Xiaozeng Wang, et al.
Nutrients (2023) Vol. 15, Iss. 12, pp. 2808-2808
Open Access | Times Cited: 34
Triglyceride-rich lipoproteins, remnant-cholesterol, and atherosclerotic cardiovascular disease
Om P Ganda
Current Opinion in Lipidology (2023) Vol. 34, Iss. 3, pp. 105-113
Closed Access | Times Cited: 28
Triglyceride-Rich Lipoprotein Metabolism: Key Regulators of Their Flux
Alejandro Gugliucci
Journal of Clinical Medicine (2023) Vol. 12, Iss. 13, pp. 4399-4399
Open Access | Times Cited: 28
The chylomicron saga: time to focus on postprandial metabolism
Alejandro Gugliucci
Frontiers in Endocrinology (2024) Vol. 14
Open Access | Times Cited: 12
Competitive displacement of lipoprotein lipase from heparan sulfate is orchestrated by a disordered acidic cluster in GPIHBP1
Anamika Biswas, Samina Arshid, Kristian Kølby Kristensen, et al.
Journal of Lipid Research (2025), pp. 100745-100745
Open Access | Times Cited: 1
Exploring apolipoprotein C-III: pathophysiological and pharmacological relevance
Chris J. Packard, Angela Pirillo, Sotirios Tsimikas, et al.
Cardiovascular Research (2023) Vol. 119, Iss. 18, pp. 2843-2857
Open Access | Times Cited: 18
Highly Valuable Fish Oil: Formation Process, Enrichment, Subsequent Utilization, and Storage of Eicosapentaenoic Acid Ethyl Esters
Mengyuan Yi, Yue You, Yiren Zhang, et al.
Molecules (2023) Vol. 28, Iss. 2, pp. 672-672
Open Access | Times Cited: 17
Plasma metabolites of a healthy lifestyle in relation to mortality and longevity: Four prospective US cohort studies
Anne‐Julie Tessier, Fenglei Wang, Liming Liang, et al.
Med (2024) Vol. 5, Iss. 3, pp. 224-238.e5
Open Access | Times Cited: 7
Triglyceride-rich lipoproteins and cardiovascular diseases
Dandan Xu, Lin Xie, Cheng Cheng, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 7
The Role of Triglycerides in Atherosclerosis: Recent Pathophysiologic Insights and Therapeutic Implications
Yonatan Akivis, Hussam Alkaissi, Samy I. McFarlane, et al.
Current Cardiology Reviews (2024) Vol. 20, Iss. 2
Closed Access | Times Cited: 6
Biosynthesis and Metabolism of ApoB-Containing Lipoproteins
Jan Borén, Marja‐Riitta Taskinen, Chris J. Packard
Annual Review of Nutrition (2024) Vol. 44, Iss. 1, pp. 179-204
Closed Access | Times Cited: 6
Hypercholesterolemia and inflammation—Cooperative cardiovascular risk factors
Antonio Gallo, Wilfried Le Goff, Raul D. Santos, et al.
European Journal of Clinical Investigation (2024)
Open Access | Times Cited: 6
Remnant cholesterol and atherosclerotic cardiovascular disease: Metabolism, mechanism, evidence, and treatment
Kexin Wang, Rui Wang, Jiaxin Yang, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 23
Metabolic disorders and risk of cardiovascular diseases: a two-sample mendelian randomization study
Zhe Wang, Jiawei Chen, Longyang Zhu, et al.
BMC Cardiovascular Disorders (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 14
Page 1 - Next Page

Scroll to top